Effect of vasoactive intestinal polypeptide on development of migraine headaches
1. Vasoactive intestinal polypeptide may play a key role in the mechanism of migraine pathogenesis. 2. Drug therapies targeting vasoactive ...
1. Vasoactive intestinal polypeptide may play a key role in the mechanism of migraine pathogenesis. 2. Drug therapies targeting vasoactive ...
1. Intravenous eptinezumab-treated participants achieved significantly earlier freedom from headaches and from their most bothersome symptoms compared to placebo in ...
1. For patients with medication overuse headache, withdrawal and preventive medication was more effective at reducing headache than other strategy ...
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 1. In patients with ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
1. Patients with episode cluster headaches randomized to receive galcanezumab experienced a greater decline in frequency of headaches 1 to ...
1. Patients with migraine treated with rimegepant during an acute event had resolution of pain and their most bothersome symptoms ...
1. Patients with episode cluster headaches randomized to receive galcanezumab experienced a greater decline in frequency of headaches 1 to ...
1. Patients with migraine treated with rimegepant during an acute event had resolution of pain and their most bothersome symptoms ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.